Hinge Health (HNGE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for June 3, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 2, 2026, 11:59 PM ET.
Voting matters and shareholder proposals
Election of two Class I directors: Teddie Wardi and Tyler Sloat, with board recommending a vote for both.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Other business may be addressed as appropriate during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Hinge Health
- Record 2025 revenue, 83% gross margin, and 97% retention; strong 2026 outlook.HNGE
Q4 202521 Apr 2026 - Director elections, auditor ratification, and strong governance with equity-focused compensation.HNGE
Proxy filing17 Apr 2026 - IPO highlights strong growth, high retention, and tech-driven MSK care with dual-class structure.HNGE
Registration Filing29 Nov 2025 - AI-driven MSK care platform posts 33% revenue growth, strong margins, and targets global expansion.HNGE
Registration Filing29 Nov 2025 - IPO targets $230M+ net proceeds, strong growth, but most funds go to RSU tax obligations.HNGE
Registration Filing29 Nov 2025 - Digital MSK care platform targets $230.7M IPO, focusing on growth and tax obligations.HNGE
Registration Filing29 Nov 2025 - AI-driven MSK care platform with rapid growth and high retention targets $18B+ market in IPO.HNGE
Registration Filing29 Nov 2025 - Q2 2025 revenue rose 55% to $139.1M, with strong margins and IPO-related net loss.HNGE
Q2 202523 Nov 2025 - Q3 revenue up 53% to $154.2M, margins and cash flow surged, guidance raised for 2025.HNGE
Q3 202513 Nov 2025